Work

Bulumtatug fuvedotin (BFv; 9MW2821) plus toripalimab in perioperative patients with muscle-invasive bladder cancer (MIBC): Results of cohort A from a phase 2 study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4609

Authors: Zhuowei Liu, Shusuan Jiang, Minfeng Chen, Zhisong He, Jingming Dong, Peipei Wang, Shuhai Wang

Institutions: Sun Yat-sen University Cancer Center, Hunan Cancer Hospital, Central South University, Xiangya Hospital Central South University, Peking University, Peking University First Hospital

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162509296

Cites:

Cited by:

Related to: